Press Releases ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Delayed Nasdaq Other stock markets 03:48:58 2024-04-29 pm EDT			5-day change	1st Jan Change
65.45 ^USD	+0.14%		-0.11%	+18.87%

Apr. 17	Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing	MT
Apr. 09	ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET	Apr. 18	AQ
ANI Pharmaceuticals : Corporate Presentation - April 2024	Apr. 17	PU
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension	Apr. 09	AQ
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis	Apr. 04	AQ
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium	Apr. 03	AQ
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP	Mar. 27	AQ
ANI Pharmaceuticals : Corporate Presentation - March 2024	Mar. 12	PU
ANI: Q4 Earnings Snapshot	Feb. 29	AQ
ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance	Feb. 29	AQ
ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference	Feb. 20	AQ
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET	Feb. 07	AQ
ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks \| 6th Annual Biotechnology Conference	Jan. 29	AQ
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP	Jan. 23	AQ
ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP	Jan. 16	AQ
ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference	Nov. 22	AQ
ANI: Q3 Earnings Snapshot	Nov. 08	AQ
ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance	Nov. 08	AQ
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences	23-10-30	AQ
ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET	23-10-25	AQ
ANI PHARMACEUTICALS ANNOUNCES FDA APPROVAL AND COMMERCIAL AVAILABILITY OF NEW 1-ML VIAL SIZE OF PURIFIED CORTROPHIN GEL, APPROPRIATE FOR ADJUNCTIVE TREATMENT OF CERTAIN PATIENTS WITH ACUTE GOUTY ARTHRITIS FLARES	23-10-03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Press Releases

Filters